MiR-519d Impedes Cisplatin-Resistance in Breast Cancer Stem Cells by Down-Regulating the Expression of McL-1

Oncotarget - United States
doi 10.18632/oncotarget.15781
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

FTY720 Enhances TRAIL-mediated Apoptosis by Up-Regulating DR5 and Down-Regulating McL-1 in Cancer Cells

Oncotarget
Oncology
2015English

miR-1 Inhibits the Proliferation of Breast Cancer Stem Cells by Targeting EVI-1

OncoTargets and Therapy
OncologyPharmacology
2018English

Phenylethyl Isothiocyanate Reverses Cisplatin Resistance in Biliary Tract Cancer Cells via Glutathionylation-Dependent Degradation of McL-1

Oncotarget
Oncology
2016English

MicroRNA-224 Inhibits Proliferation and Migration of Breast Cancer Cells by Down-Regulating Frizzled 5 Expression

Oncotarget
Oncology
2016English

LncRNA NEAT1 Enhances the Resistance of Anaplastic Thyroid Carcinoma Cells to Cisplatin by Sponging miR‑9‑5p and Regulating SPAG9 Expression

International Journal of Oncology
Cancer ResearchOncology
2019English

Enhancing Chemosensitivity of Breast Cancer Stem Cells by Down Regulating SOX2 and ABCG2 Using Wedelolactone-Encapsulated Nanoparticles

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2010English

Breast Cancer Stem Cells in Antiestrogen Resistance

2013English

Celecoxib Targets Breast Cancer Stem Cells by Inhibiting the Synthesis of Prostaglandin E2 and Down-Regulating the WNT Pathway Activity

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy